Yvoire Fillers: What the Name Includes and How Versions Differ

You may have seen Yvoire in a list of fillers or heard its name during a consultation and wondered how it differs from other products. Rather than searching for the “best Yvoire”, ask which exact version is proposed, for what purpose and why it suits your anatomy. Yvoire is a family of injectable hyaluronic-acid (HA) fillers made by South Korea’s LG Chem, not one universal formulation. Its gels differ in mechanical behaviour: a product for gently softening a fold and one designed to support volume are not necessarily interchangeable.

The gel is injected into tissue to change its surface, volume or contours temporarily. It cannot surgically lift excess skin, treat every cause of wrinkles or promise the same result in two people. Certain Yvoire formulations have clinical studies, but evidence from nasolabial folds (creases running from the nose towards the mouth) cannot simply be transferred to lips, under-eye areas or a different formula. Once you know the brand, the next conversation should be about its precise version, site, intended change, limitations and emergency plan.

What exactly does the name Yvoire include?

LG Chem’s international catalogue describes Classic, Volume and Contour, lidocaine-containing options and other lines including Y-Solution 360, 540 and 720. The manufacturer distinguishes their material characteristics and proposed uses. Cross-linked HA means molecular chains have been joined to make an injectable gel more resistant to breakdown. Shape retention, flexibility and tissue spread vary by formula. Numbers and names alone do not specify an appropriate dose or injection depth for you: the exact product’s current local instructions and a clinical examination must guide those decisions.

Lidocaine matters, too: some products contain this local anaesthetic. Tell the clinician about allergies or significant previous reactions. LG Chem describes different syringe volumes and pack contents, which may differ across markets. Ask to see the actual box and instructions before treatment rather than trusting an advertising photograph. Classic s, Classic Plus and Classic without a suffix cannot automatically be assumed to mean the same device.

This comparison is for discussion, not an injection prescription. Product families may differ by market. Without current local labelling, precise indications, injection depths or absolute contraindications cannot be assigned to every table row. In particular, “with lidocaine” only describes the relevant version and does not replace checking its complete ingredients.

What might change in the mirror—and what cannot Yvoire fix?

If you are concerned about a fold beside the nose, the clinician should examine whether facial structure, changing fat-pad distribution, muscle movement or several factors cause it. Filling a selected area may soften the transition; trying to erase the line completely can instead create unwanted volume around the mouth. Translate “I still want to look like myself” into specific goals: a gentler shadow at rest, without larger cheeks or a changed smile. This helps avoid drifting into repeated injections by habit.

If your main concern is loose skin, marked tissue descent, dynamic forehead wrinkles or uneven pigmentation, filler may be the wrong tool. An HA gel supports or adds local volume; it is not an HA skincare serum and cannot substitute for a surgical lift. Previous fillers deserve special attention: residual material, inflammatory lumps and asymmetry need evaluation before another injection, sometimes with ultrasound, rather than automatically adding more millilitres.

What do studies specifically of Yvoire show?

Two randomized comparator trials evaluated Yvoire Classic s against Restylane in 58 participants and Yvoire Volume s against Perlane in 57 participants for nasolabial folds. At 26 weeks, these specific formulations met the studies’ predefined noninferiority criteria relative to their respective comparators. That is meaningful but narrow evidence: it concerns particular formulas, one area and one observation period. The authors were LG Chem employees; industry funding and conflicts of interest should be considered when assessing certainty.

Two later observational studies enrolled 503 people each, receiving Classic s or Volume s in nasolabial folds, with longer follow-up. In most participants, fold-severity scores returned to baseline within the first year. However, the study’s “clinical biodegradation” endpoint was based on the visible fold score, not direct proof that no gel remained anywhere in the tissue. This distinction matters when advertising promises an exact date of “complete dissolution”. Residual gel may persist longer and personal timing cannot be predicted precisely.

Do not present these findings as equivalent trials of Contour, Y-Solution or differently named products. Trial registration tells you research was registered, not that results have been published. Published studies through October 2026 do not offer enough independent, direct comparisons among all Yvoire versions and current alternatives to call any one product universally best for naturalness, duration or safety.

How can you assess whether a particular version suits you?

A useful consultation starts with your face at rest and smiling, not with a syringe choice. Discuss previous injections and surgery, immune or skin conditions, infections, unusually strong reactions, medicines affecting clotting and allergies. Inflamed areas or herpes outbreaks near the intended site warrant attention. Safety during pregnancy and breastfeeding has not been established for cosmetic fillers, so postponing an elective injection is prudent.

Bleeding disorders and anticoagulant medication make individual assessment especially important. Never stop prescribed medicines just to have filler. Active skin inflammation or infection calls for postponement until it has been addressed. A significant lidocaine allergy requires checking the exact ingredients and a medical assessment. If an earlier procedure went badly, reconstruct what was injected and where before considering another; embarrassment is no reason to withhold the history.

How does treatment feel?

Before injecting, the clinician normally discusses your goal, seeks informed consent, checks the skin, takes baseline photos with your permission and cleans the site. A needle or cannula may be chosen depending on the area and the clinician’s expertise. Topical or local anaesthesia and lidocaine in certain formulations may reduce discomfort but cannot guarantee a pain-free procedure. You may feel pressure, stinging or stretching; unusual severe pain must be reported immediately, not tolerated silently.

Do not proceed without knowing the complete product name, expiry date, intact sterile packaging and who will provide follow-up. Before/after photographs should use comparable angles, lighting, facial expression and time since injection. A day-after image, when swelling is present, cannot show stable volume. A remarkably low price is not proof of a fake, just as a high price cannot establish authenticity or quality.

The first days: when will I feel comfortable being seen?

Redness, tenderness, mild swelling, temporary swelling-related asymmetry and bruises can occur after injection. They commonly settle over days to weeks, but there is no universal timetable. Your reflection may look unexpectedly full on day one; some of that fullness may fade as swelling decreases, while a bruise may become more visible later. No article can promise that you will look completely untreated on day three.

Computer work may be possible quite soon, but social downtime is different. People might notice puffiness; makeup may not entirely cover bruising and side lighting can make unevenness more obvious in photographs. Leave a generous buffer before an important event and feel free to decline treatment when the date is too close. Follow your own clinician’s advice about makeup, massage, exercise, sauna and sleeping positions: the area, technique and early reactions matter. Do not vigorously massage the gel yourself.

Which symptoms are not ordinary swelling?

Seek emergency care immediately for vision changes, sudden weakness, facial droop, speech difficulties or an unusually severe headache. Escalating or disproportionate pain, whitening, grey-blue or mottled skin, or unusually cold skin during or after injection need urgent assessment for impaired blood flow. Do not wait until morning or try to massage the site at home. Impaired blood flow may occur without severe pain: skin-colour or vision changes alone require urgent assessment. Even a highly experienced injector cannot promise zero risk of intravascular injection.

Lumps, inflammation, painful redness, signs of infection or migration can appear later. These require a diagnosis: not every lump is residual filler and not every swelling needs dissolving. Hyaluronidase is an enzyme that can break down HA in appropriate clinical circumstances, including some vascular emergencies. It is not a guaranteed undo button: it has limits and its own risks; repeated intervention or additional treatment may be needed.

Yvoire versus other products: a fair comparison

Compare five things rather than logos: your goal, the exact formula, evidence for the proposed site, injector qualifications and access to help if problems occur. Restylane and Perlane were comparators in the Classic s and Volume s trials; this does not make every product from those families interchangeable. Other HA fillers can have different properties and instructions, while calcium-hydroxylapatite or other filler materials differ in how their complications are managed. The broader HA-filler article explains the material class.

Regulation matters. Korean or other approvals, study outcomes and a promotional manufacturer catalogue do not demonstrate that a particular Yvoire version is registered in Armenia, available at a clinic or authorised for the intended site. Request documentation for the exact product, verifiable supply information, locally applicable instructions and an emergency contact plan. US, European and Korean regulatory systems are distinct; a category-wide approval is not a personal authorisation for Yvoire.

What to take away from the consultation even if you do nothing

A worthwhile consultation ends in a clear plan, not a required purchase. You should know which Yvoire version is proposed, which one or two features might change, what will stay the same, how the result will be reviewed after swelling and whether a smaller intervention is possible. Ask about the product’s original packaging and batch identification, the clinician’s experience in this anatomical region, possible complications, urgent contacts and follow-up adjustments. You can always ask for more time.

If the only answers are “completely safe”, “always lasts precisely two years” or “all versions are identical”, you do not yet have a sound basis for consent. A review may instead suggest skincare, observation, a different method or no procedure at all. Those are legitimate, respectful outcomes too.